Sharf B, Moskovitz C, Lupton M D, Klawans H L
J Neural Transm. 1978;43(2):143-51. doi: 10.1007/BF01579073.
Twenty-seven of eighty-eight (30.7%) Parkinsonian patients on chronic levodopa or levodopa/carbidopa therapy developed drug related dream phenomena. The patients reported three separate types of new dreams which we have classified as vivid dreams, night terrors and nightmares. These dreams are correlated to the duration of levodopa therapy although the mechanism of their production is unclear.
88名接受慢性左旋多巴或左旋多巴/卡比多巴治疗的帕金森病患者中有27名（30.7%）出现了与药物相关的梦境现象。患者报告了三种不同类型的新梦境，我们将其分类为生动梦境、夜惊和噩梦。这些梦境与左旋多巴治疗的持续时间相关，但其产生机制尚不清楚。
